XFOR Competitors & Alternatives
Compare X4 Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
XFOR
Main Stock$3.12
Tradestie Score
40
Market Cap
$81.27M
P/E Ratio
5.8
Revenue Growth
0.6%
Analyst Upside
+271.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$9.53
|
$357.51M | - | 31 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.79
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$10.28
|
$354.45M | - | 46 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$43.01
|
$353.70M | - | 35 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.92
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.89
|
$328.62M | - | 26 | Compare |
|
MREO
Mereo BioPharma Group plc American Depositary Shares
|
$0.31
|
$326.15M | - | 53 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$8.15
|
$307.12M | - | 36 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$6.20
|
$304.12M | - | 51 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$16.14
|
$297.23M | - | 33 | Compare |
More XFOR Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry